With respect to potential molecular mechanisms that can explain how elevated SEC62 expression mediates resistance to chemoradiation associated with poor prognosis, one can hypothesize that an increased ER stress tolerance mediated by SEC62 might counteract the therapeutic effects of CRT in head and neck cancer cells. Here, SEC62 is linked to head and neck cancer.